Skip Navigation



Hum. Reprod. Advance Access published online on June 3, 2004
Human Reproduction, doi:10.1093/humrep/deh291
© 2004 by European Society of Human Reproduction and Embryology
This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
19/7/1655    most recent
deh291v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Davis, A.R.
Right arrow Articles by Zhang, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davis, A.R.
Right arrow Articles by Zhang, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received January 15, 2004
Accepted April 5, 2004

Article

Bleeding patterns after vaginal misoprostol for treatment of early pregnancy failure

A.R. Davis 1, C.M. Robilotto 1, C.L. Westhoff 1, S. Forman 2, J. Zhang 3

1 Department of Obstetrics and Gynecology, Columbia University, 630 West 168th Street, New York, NY 10032, USA
2 Clinical Trials and Surveys Corporation, 2 Hamill Road, Suite 350 West Quadrangle, Baltimore, MD 21210-1874, USA
3 Epidemiology Branch, National Institute of Child Health and Human Development, National Institute of Health, 6100 Executive Blvd, Room 7B03, Rockville, MD 20852, USA


  Abstract

BACKGROUND: Dilatation and curettage (D&C) has been the usual treatment for early pregnancy failure (EPF). Medical management with misoprostol may be an effective alternative. Bleeding patterns during and after medical management of EPF are unknown. METHODS: A prospective cohort study was conducted at University-based clinics and physician offices. Eighty women <11 weeks estimated gestational age with a diagnosis of missed abortion or fetal demise were enrolled. Treatment consisted of either 800 µg of moistened (2 ml of saline) or dry vaginal misoprostol. Self-reported bleeding and sanitary product usage were recorded in a daily 2 week diary. Haemoglobin was assessed at enrolment and 2 weeks later. RESULTS: After misoprostol treatment, patients reported bleeding or spotting every day for the 14 days observed. Self-assessed heavy bleeding days were few (median 3) and usually occurred immediately after treatment. Sanitary pad use was highly variable (mean 30.5, range 2-125 pads over the 2 week period) and not related to changes in haemoglobin. The mean decrease in haemoglobin was 0.5 g/dl (SD 1.2). Complete expulsion without D&C occurred in 85% of subjects. CONCLUSIONS: Bleeding for at least 2 weeks after vaginal misoprostol for EPF is common. Heavy bleeding is usually limited to a few days after treatment. Clinically important changes in haemoglobin are rare.

Key words: bleeding/early pregnancy failure/misoprostol


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 The Obstetrician and GynaecologistHome page
H. Sagili and M. Divers
Modern management of miscarriage
Obstet Gynaecol (Lond), April 1, 2007; 9(2): 102 - 108.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.